Alliance Pharma – product rights acquisition, looks good

Published 50 days ago

Alliance Pharma (APH) has announced a $7.5 million acquisition from medical technology company Smith & Nephew, with CEO John Dawson emphasising “the acquisition will be immediately earnings enhancing, accretive to our underlying return on invested capital, and it fits well in our existing bedrock business operations”

Video: John Dawson, CEO of Alliance Pharma, speaks at UK Investor Show 2017

Published 282 days ago

In this video from the storming success that was the 2017 UK Investor Show, John Dawson, CEO of Alliance Pharma (APH), is at the podium. And make sure that you keep April 21 2018 free for next year's UK Investor Show.

Video: John Dawson of Alliance Pharma presents at UK Investor Show

Published 614 days ago

Alliance Pharma (APH) has, relatively, recently completed a transformational acquisition. I know that Nigel Wray remains a big fan as does Mark Slater. Sensible value investors should thus find the presentation by John Dawson of interest

Video of the healthcare and biotech masterclass at Uk Investor 2015

Published 990 days ago

Amiong those presenting in the healthcare and biotech master class were John Dawson of Alliance Pharma, Steve Moore, Adam Reynolds of Premaitha and Optibiotix, Venn Life and Collagen. Enjoy

Hear Nigel Wray (and TW) fave Alliance Pharma this Thursday (23rd) and get free food

Published 1007 days ago

Alliance Pharma (APH) is a stock that Britain’s Buffett had held for ten years and it is also a great sleep-sound core portfolio buy for me.  Its CEO John Dawson is a good man and I like the company. Anyhow he, and the CEOs of Rex Bionics, Accesso and Akers Biosciences, of which I know sweet FA are presenting in London at the Proactive forum this Thursday 23rd). There’s free food & booze on offer as well. And


About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /